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Abstract
Background: Endometrial ablation (EA) is a frequently used treatment for abnormal uterine bleeding, mainly due to
the low risks, low costs and short recovery time associated with the procedure. On the short term, it seems successful,
long-term follow-up however, shows decreasing patient satisfaction as well as treament efficacy. There even is a post-
ablation hysterectomy rate up to 21%. Multiple factors seem to` influence the outcome of EA. Due to dissimilarities in and
variety of these factors, it has not been possible so far to predict the success rate of EA based on pre-operative factors.
Therefore, the aim of this study is to develop two prediction models to help counsel patients for failure of EA or necessity
of surgical re-intervention within 2 years after EA.
Methods: We designed a retrospective two-centred cohort study in Catharina Hospital, Eindhoven and Elkerliek
Hospital, Helmond, both non-university teaching hospitals in the Netherlands. The study population consisted of
446 pre-menopausal women who underwent EA for abnormal uterine bleeding, with a minimum follow-up time
of 2 years. Multivariate logistic regression analysis was used to create the prediction models.
Results: The mean age of the patients was 43.8 years (range 20–55), 97.3% had complaints of menorrhagia,
57.4% of dysmenorrhoea and 61.0% had complaints of intermittent or irregular bleeding. 18.8% of patients
still needed a hysterectomy after EA. The risk of re-intervention was significantly greater in women with
menstrual duration > 7 days or a previous caesarean section, while pre-operative menorrhagia was significantly associated
with success of EA. Younger age, parity ≥ 5 and dysmenorrhea were significant multivariate predictors in both models.
These predictors were used to develop prediction models, which had a C-index of 0.71 and 0.68 respectively.
Conclusion: We propose two multivariate models to predict the chance of failure and surgical re-intervention
within 2 years after EA. Due to the permanent character of EA, the increasing number of post-operative failure
and re-interventions, these prediction models could be useful for both the doctor and patient and may
contribute to the shared decision-making.
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Article
The use of EA as treatment for abnormal uterine bleeding is
rapidly increasing. This surgical outpatient procedure offers
a minimally invasive alternative for hysterectomy in case
non-surgical treatment is not effective. The success of EA is
mainly based on the short recovery time, low risks and low
costs associated with the procedure. [1–5] In contrast to the
short-term success, long-term follow-up shows decreasing
patient satisfaction as well as treatment efficacy [6–13]. A
common complaint of patients after EA is pain (20–23%),
which often leads to re-interventions [7, 8]. Besides the oc-
currence, persistence or aggravation of pain, another reason
for re-intervention can be persisting bleeding disturbances
[7, 10]. Retrospective cohort data reveal a post-ablation hys-
terectomy rate up to 21% [6, 8–10, 12, 14–16].
Several factors influencing failure of EA have been
reported. It has been shown that the probability of
success increases with older age at the time of
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intervention. [6, 8–12, 14, 17, 18] Prior studies dem-
onstrated different negative influencing factors, such
as the duration of pre-operative menstruation, dys-
menorrhea, the position of the uterus and the thick-
ness of the endometrium [6, 7, 9–13, 15, 19, 20].
However, due to dissimilarities in and variety of the
factors previously described, it has not been possible
so far to predict the success rate of EA based on
pre-operative factors. Patient counselling is therefore
difficult.
The aim of this study was to develop two predic-
tion models to counsel patients for failure of EA and
for surgical re-intervention within 2 years. In addition,
we established the hysterectomy rate, the additional
treatment rate and the patient satisfaction after EA.
Methods
This retrospective two-centred cohort study included
patients with EA for complaints of abnormal uterine
bleeding in two non-university teaching hospitals in the
Netherlands (the Catharina Hospital in Eindhoven and
the Elkerliek Hospital in Helmond). In both hospitals,
similar ablation techniques were used between 2004 and
2013, namely Cavatherm® (Veldana Medical SA, Morges,
Switzerland), Thermablate® EAS (Idoman, Ireland) and
Gynecare Thermachoice® (Ethicon, Sommerville, US).
Previous research showed that these techniques were
equal in effectivity [13, 21]. The study was approved by
the local medical ethical review board. All patients gave
informed consent.
Patients
Patients were identified in the Electronic Patient Care
System using the following search terms: endometrial
ablation, balloon-coagulation endometrium, coagula-
tion uterus and endoresection: hysteroscopic exten-
sive. The retrieved cases were verified by means of
chart review.
Patients were excluded if they were post-menopausal
at the time of treatment, if they had or were suspected
of having an endometrial malignancy or if they had uter-
ine cavity deformations (anomalies, fibroids, adenomyo-
sis or a polyp).
Follow-up period after EA was at least 2 years, since
earlier research showed that most re-interventions took
place in this post-operative 2-year period [8, 15, 20–24].
Follow-up ended on the day of hysterectomy, in case of
death or on April 15, 2015.
Data extraction
Two researchers extracted all the data from individual
patient files. Patients were requested to complete a ques-
tionnaire concerning follow-up information. In case of
non-response, patients were contacted by letter again
and ultimately by telephone. The questionnaire com-
prised questions based on significant factors previously
published [6, 9–15, 17–20]. Charts and patient responses
were used to obtain post-procedural information on
menstrual pattern, patient satisfaction, additional treat-
ment and pathology results in case a hysterectomy was
performed.
Abnormal blood loss as procedure outcome was de-
fined by a combination of intermittent or irregular
bleeding and heavy menstrual bleeding (HMB) following
EA. Treatment prior to EA was defined as any treatment
for abnormal uterine bleeding performed prior to sur-
gery. Satisfaction was evaluated on a four-point scale (1:
very satisfied, 2: satisfied, 3: dissatisfied, 4: very dissatis-
fied). During analysis, we combined the answers scoring
1 and 2 points as ‘satisfied’ and those scoring 3 and 4
points as ‘dissatisfied’.
Outcomes
The primary aim of this study was to identify signifi-
cant predictors of failure of EA and surgical
re-intervention within 2 years after EA by construct-
ing a prediction model for each outcome. Failure was
defined as pelvic pain, abnormal blood loss or dissat-
isfaction after the procedure. Secondary outcomes of
this study were hysterectomy rate, patient satisfaction
and percentage of additional treatment after EA, for
example hormonal treatment, re-ablation or endomet-
rial resection.
Statistical analysis
Statistical analysis was performed using the statistical
package IBM SPSS statistics, software version 21.0
(IBM Corp., Armonk, NY, USA). Continuous variables
were presented as mean and standard deviation or
median and minimum-maximum, depending on nor-
mality. Categorical variables were reported as
frequencies.
Univariable logistic regression analysis was used to de-
termine which predictive factors were significant. Corre-
sponding odds ratios (OR) and 95% confidence intervals
(CI) were given.
Predictive factors with a p value <.10 were used in the
multivariable analysis. A manual selection process was
done by progressively excluding the variable with the
highest p value.
The p value of 0.10 was chosen because, as Steyerberg
et al. stated, an incorrect exclusion of a variable would
be far more detrimental than considering to put in a fac-
tor too many [25, 26].
Possible interaction between the significant predictors
in the model was tested using interaction terms. Further-
more, multicollinearity was tested.
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The overall fit of the model was tested using the
C-index (area under the curve). A value of 1.0 for the
C-index implies a perfectly produced model, where
every prediction made with the variables in the model
is true. However, a value of 0.5 implies that the
model gives information that is equal to that given by
the probability on its own. Values over 0.7 indicate a
good model, whereas values over 0.8 indicate a strong
model [27, 28].
The regression model was internally validated with
bootstrap resampling (n = 5000) [29–33]. Regression co-
efficients of the model were multiplied by the shrinkage
factor to correct for over-optimism of the original
model.
Results
In this study, 762 patients were identified. After examin-
ation of patient records, 33 patients were excluded; 30
patients did not completely fulfil the inclusion criteria
(e.g. malignancy, cavity deformations) and 3 patients had
an incomplete ablation procedure.
The remaining 729 participants were contacted, of
whom 283 did not respond despite our best efforts. This
resulted in 446 included patients, which represents a re-
sponse rate of 61% (Fig. 1).
The baseline patient characteristics are listed in
Table 1. The mean age of the patients at the time of EA
was 43.8 years (SD ± 5.5, range 20–55). The mean BMI
was 26.5 kg/m2 (SD ± 4.7). A mean number of parity of
2.2 (SD ± 1.0) was observed; 13.7% of the women had
undergone a previous caesarean section.
Menorrhagia was present in 97.3% of patients, 61%
had complaints of intermittent or irregular bleeding and
57.4% had complaints of dysmenorrhea. In 39.4% of pa-
tients, the duration of the menstruation was longer than
7 days (Table 1).
Fig. 1 Enrolment and allocation of patients
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Re-intervention model
In the study group, 11.9% (n = 53) of the patients
needed a surgical re-intervention within 2 years after
EA. Univariate analyses showed that the following
pre-operative variables were significantly associated
with a higher probability of getting a surgical
re-intervention within 2 years after EA (p < .05): age
(OR 0.93, 95% CI 0.89–0.98), dysmenorrhea (OR 2.83,
95% CI 1.44–5.55), length of menstruation > 7 days
(OR 1.87, 95% CI 1.04–3.37), parity ≥ 5 (OR 5.84,
95% CI 1.27–26.83), previous caesarean section (OR
2.98, 95% CI 1.52–5.83) and pre-treatment (OR 0.40,
95% CI 0.16–0.95) (Table 2). These pre-operative vari-
ables were included in the multivariate analyses.
In the final prediction model after multivariate
analysis, the following pre-operative variables were
significant: age (OR 0.95, 95% CI 0.90–1.00), dys-
menorrhea (OR 2.48, 95% CI 1.21–5.07), length of
menstruation > 7 days (OR 2.05, 95% CI 1.10–3.82),
previous caesarean section (OR 2.21, 95% CI 1.05–
4.64) and parity ≥ 5 (OR 7.63, 95% CI 1.51–38.46)
(Table 2). The C-index of the model was 0.71.
No two-way interaction and multicollinearity between
the variables was detected.
The shrinkage factor of 0.823 was used to correct the
model.
Table 1 Baseline patient characteristics (N = 446)
Characteristic * Value**
Age (years) 43.8 ± 5.5
Body mass index (kg/m2) 26.5 ± 4.7
Dysmenorrhea 57.4%
Follow-up time (days) 1693.8 ± 871.9
Duration of menstruation > 7 days (n = 429) 39.4%
Intermittent or irregular bleeding 61.0%
Length of the uterus (cm) (n = 402) 9.1 ± 1.1
Menorrhagia 97.3%
Parity (no.) 2.2 ± 1.0
Previous caesarean section 13.7%
Smoking (n = 445) 21.6%
Sterilisation (n = 444) 26.1%
Uterus position (n = 296)
Anteverted 72.3%
Retroverted 23.6%
Midposition 4.1%
*n = 446 unless otherwise mentioned
**Mean ± SD or a percentage
Table 2 Pre-operative predictors of re-intervention after endometrial ablation
Univariate analysis Multivariate analysis
Variable Odds ratio 95% CI p value Odds ratio 95% CI p value β
Age (years) 0.93 0.89–0.98 <.01 0.95 0.90–1.00 .06 − 0.052
Body mass index (kg/m2) 0.99 0.93–1.05 .68
Dysmenorrhea 2.83 1.44–5.55 <.01 2.48 1.21–5.07 .01 0.097
Duration of menstruation > 7 days 1.87 1.04–3.37 .04 2.05 1.10–3.82 .02 0.718
Intermittent or irregular bleeding 1.56 0.84–2.89 .16
Menorrhagia 0.67 0.14–3.12 .61
Myomas 0.67 0.30–1.48 .33
Parity (no.) 0.88 0.66–1.17 .38
Parity ≥ 5 5.84 1.27–26.83 .02 7.63 1.51–38.46 .01 2.032
Pre-treatment* 0.40 0.16–0.95 .04 0.49 0.20–1.22 .13 –
Previous caesarean section 2.98 1.52–5.83 <.01 2.21 1.05–4.64 .04 0.794
Smoking 1.36 0.70–2.62 .36
Sterilisation 1.59 0.86–2.94 .14
Total endometrial thickness
Thin, 0–3 mm 0.64 0.18–2.29 .49
Normal, 4–12 mm 1.00 – –
Thick, > 13 mm 0.96 0.36–2.58 .93
Uterine cavity length of the uterus (cm) 1.16 0.88–1.54 .29
Uterus position
Anteverted 1.00 – –
Retroverted 1.23 0.54–2.79 .63
Midposition 2.77 0.70–10.96 .15
*Any form of treatment (medicamentous or surgical) prior to the EA
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The final model after application of the shrinkage fac-
tor is as follows:
Failure model
In the study group, 35.8% (n = 160) of the EA failed.
Univariate analyses showed that the following
pre-operative variables were significantly associated
with a higher probability of failure of EA (p < .05):
age (OR 0.93, 95% CI 0.89–0.96), dysmenorrhea (OR
2.14, 95% CI 1.42–3.23), menorrhagia (OR 0.27, 95%
CI 0.08–0.91) and parity ≥ 5 (OR 11.17, 95% CI 1.33–
93.60) (Table 3). The pre-operative variables with a p
value p < .10 were also included in the multivariate
analyses; these were total endometrial thickness and
pre-treatment.
In the final prediction model after multivariate ana-
lyses, the following pre-operative variables were signifi-
cant: age (OR 0.93, 95% CI 0.90–0.97), dysmenorrhea
(OR 2.11, 95% CI 1.37–3.26), menorrhagia (OR 0.21,
95% CI 0.06–0.77) and parity≥ 5 (OR 11.19, 95% CI
1.30–96.51) (Table 3). The C-index of the model was
0.68.
No two-way interaction and multicollinearity between
the variables was detected.
The shrinkage factor of 0.904 was used to correct the
model.
The final model is as follows:
Other results
Our results showed that 82.6% (n = 368) of patients were
satisfied with the outcome of EA, and 86.8% (n = 387) of
patients would recommend EA to a friend.
Of the satisfied group, 14.6% (n = 54) of patients had
a new medical therapy or a surgical re-intervention.
Furthermore, 32.7% (n = 146) of the total population
had an additional treatment after EA, varying from hor-
monal to surgical intervention.
The hysterectomy rate was 18.8% (n = 83), and 61% (n
= 51) of this group had surgery within 2 years after EA.
A total of 22.9% (n = 102) of the study population had
additional surgical treatment, 52% (n = 53) of whom
within 2 years after EA. Besides the number of smokers,
there was no significant difference between the baseline
data and the hysterectomy rates between the responders
and the non-responders.
Discussion
Main findings
This study identified predictors for the outcome of EA
as a treatment of abnormal uterine bleeding; this re-
sulted in two prediction models, one for the probability
of a surgical re-intervention within 2 years after EA
(C-index 0.71) and one for the probability of failure of
EA (C-index 0.68).
Explaining the models
The significant factors seem to be in line with the previ-
ously published literature. [6, 11–15, 17–20]
An EA procedure at a younger age increases the risk
of failure due to the longer interval until menopause.
This increased time interval can also increase the risk of
new complaints or re-intervention. In our model, age
was used as a continuum, so the probability can be cal-
culated more specifically based on the exact age of the
individual patient.
The significant factor of high parity (≥ 5) is probably
due to a larger multiparous uterine cavity, which is less
congruent with an optimal fit of the ablation devices.
However, we did not find a univariate significant differ-
ence in uterine cavity length.
Previous caesarean section as a significant negative
risk factor can possibly be explained due to abnormal
bleeding caused by uterine scar defects. It is possible
that the device cannot make complete contact with
the entire surface, especially in the inner part of the
niche, leading to incomplete EA due to residual active
endometrium [34]. Furthermore, in our models,
pre-operative dysmenorrhea is associated with higher
risk of failure and surgical re-intervention.
y ¼ 1
1þ e− 3:485− age0:063ð Þþ dysmenorrhea yes¼1 no¼0ð Þ0:677ð Þþ parity ≥5 yes¼1 no¼0ð Þ2:183ð Þ− menorraghia yes¼1 no¼0ð Þ1:400ð Þð Þ
y ¼ 1
1þ e−ð−0:896− age0:046ð Þþ dysmenorrhea yes¼1 no¼0ð Þ0:008ð Þþ parity ≥5 yes¼1 no¼0ð Þ1:781ð Þþ duration of menstruation>7 yes¼1 no¼0ð Þ0:629ð Þþ previous caesarean section yes¼1 no¼0ð Þ0:700ð ÞÞ
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Adenomyosis has been suggested to be a factor influ-
encing the increased occurrence of (post-ablation)
pelvic pain [35–38]. Pain is a subjective outcome
measure. On the one hand, the level of pain can be
explained by the coping mechanism of the patient; on
the other hand, if a patient experiences many
pre-operative complaints, the cause can be multifac-
torial (e.g. coping, dysmenorrhea, adenomyosis, endo-
metriosis [37–41].
Performing ablation in patients with a certain extent
of uterine pathology (fibroids, adenomyosis) can be
seen as a risk for success of therapy [2, 34, 41, 42].
However, sensitivity and specificity of the diagnostic
tools for determining these myometrial diseases are
still low.As expected, thin endometrium is a positive
predictor for ablation success due to the increased
chance of complete penetration of heat during the
EA. In multivariate analysis, however, this no longer
was a significant factor.
Menorrhagia, defined as the subjective estimation of
heavy bleeding (e.g. increased blood clots, overall
bleeding quantity), is a patient characteristic that
seems to fit the success profile for EA. This can be
explained by the primary expected effect of EA:
reduction of endometrial surface and subsequent
bleeding.
Furthermore, we observed that pre-treatment leads to
a univariate outcome of significantly higher risk of fail-
ure or re-intervention. Multiple treatments prior to EA
can be an indication of the complexity of the underlying
cause of the uterine disorder.
Examples of using the models
In clinical practice, the models can be used to esti-
mate the risk of failure for individual patients. For in-
stance, a 38-year-old patient, para 5, with a previous
caesarean section, a menstrual duration of more than
7 days and complaints of dysmenorrhea and menor-
rhagia, has 93% chance of failure of EA and 62%
chance of surgical re-intervention within 2 years after
EA.
On the other hand, a 48-year-old woman, para 2, with
no previous caesarean section, a menstrual duration
shorter than 7 days and complaints of menorrhagia but
no dysmenorrhea, has a chance of 28% failure of EA and
4% chance of surgical re-intervention within 2 years after
EA (Table 4).
Table 3 Pre-operative predictors of failure of endometrial ablation
Univariate analysis Multivariate analysis
Variable Odds ratio 95% CI p value Odds ratio 95% CI p value β
Age (years) 0.93 0.89–0.96 <.01 0.93 0.90–0.97 <.01 − 0.070
Body mass index (kg/m2) 0.99 0.95–1.03 .61
Dysmenorrhea 2.14 1.42–3.23 <.01 2.11 1.37–3.26 <.01 0.749
Duration of menstruation > 7 days 1.26 0.84–1.89 .27
Intermittent or irregular bleeding 1.22 0.82–1.83 .33
Menorrhagia 0.27 0.08–0.91 .03 0.21 0.06–0.77 .02 − 1.544
Myomas 0.92 0.56–1.49 .72
Parity (no.) 0.88 0.73–1.07 .22
Parity ≥ 5 11.17 1.33–93.60 .03 11.19 1.30–96.51 .03 2.415
Pre-treatment 0.63 0.39–1.03 .07 0.74 0.37–1.47 .39 –
Previous caesarean section 1.57 0.90–2.72 .11
Smoking 0.73 0.45–1.18 .20
Sterilisation 1.30 0.84–2.01 .24
TED
Thin, 0–3 mm 0.94 0.47–1.85 .85 1.11 0.54–2.30 .78 –
Normal, 4–12 mm 1.00 – –
Thick, > 13 mm 0.55 0.29–1.07 .08 0.56 0.27–1.16 .12 –
Uterine cavity length (cm) 1.07 0.89–1.28 .49
Uterus position
Anteverted 1.00 – –
Retroverted 1.40 0.79–2.46 .25
Midposition 1.51 0.46–4.95 .49
*Any form of treatment (medicamentous or surgical) prior to the EA
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Other results
In accordance with the literature, our results show that
most re-interventions take place within 2 years after EA
[8, 15, 20–24].
Our study showed that 82.6% (n = 368) of patients
were satisfied with EA, and 86.8% (n = 387) would rec-
ommend it to a friend. The discrepancy between the
satisfaction and the percentage of re-interventions can
be explained by the fact that many patients stated that
they first wanted to try a minimally invasive therapy,
instead of having a major surgery such as a hysterec-
tomy. If the EA failed for them, they would still recom-
mend the treatment to others, to possibly avoid a more
invasive treatment.
As stated in previous literature, satisfaction is a diffi-
cult and subjective concept and therefore an outcome
that is less reliable as an objective parameter for suc-
cess [43–48].
Strengths and limitations
The two-centred aspect of the study ensures its representa-
tiveness. Furthermore, two researchers reviewed the charts,
and if unclear answers were given, the patients were con-
tacted by telephone to filter out wrong or misinterpreted
data.
The models were developed with the data of 446 pa-
tients, who responded to our questionnaire. The hyster-
ectomy rate in this group does not differ significantly
from that of the non-responder group. The chance of se-
lection bias therefore is minimal, although this cannot
be completely ruled out.
The most important limitation of this retrospective
study is the acquisition of data from patient charts with
a non-validated questionnaire.
Besides the calculated probability of failure and
re-intervention within 2 years, there still is a chance of hav-
ing a re-intervention after this time; this cannot be calcu-
lated with the models.
An external validation of the prediction models is
needed; this is currently being performed, using
retrospective data of similar patient groups in two
non-university teaching hospitals in the Netherlands.
Furthermore, we are currently performing a study to
investigate the impact of the models (and their cor-
responding individual percentages) in the decision of
both the patients and doctors. The influence of costs
of the treatment has not been added, although this
may influence the choice of the patient or doctor.
Therefore, this option has been added to a follow-up
questionnaire of this study.
We are aware of the fact that some of the devices in the
study are no longer used or have been updated; therefore,
in the external validation, Novasure® and Thermachoice
III® will be added.
Previous research however showed that these tech-
niques were similar effective [13, 21].
Interpretation in light of other evidence
When comparing existing literature concerning the suc-
cess rates of EA, there seems to be some inconsistency
in the importance of variables, especially when multi-
variate analyses were performed. Bongers et al. reported
that dysmenorrhoea seems less important in predicting
the outcome of EA in relation to other variables when
performing multivariate analyses [9]. In contrast to this
study, the multivariate prediction model produced by El
Nashar et al. showed young age, high parity, history of
sterilisation and pre-operative dysmenorrhea as signifi-
cant prognostic factors for failure of EA. [6]
To illustrate the discrepancies in literature, a
case-control study by Peeters et al. reported that the
outcome is not predicted by age and sterilisation, but by
pre-operative dysmenorrhea, submucous myomas and
large-sized uteri. [19]
El Nashar et al. created a model to predict ‘failure’ of EA.
Failure in this model was defined as bleeding or pain follow-
ing EA, with the necessitating of having a hysterectomy or
re-ablation. In this model, age as a continuum was not used
[6]. Comparing outcomes of our study on re-intervention
and complaints, we observed different significant variables
predicting the two types of failure of EA. Therefore, we
made two prediction models, so patients can be counselled
for the chance of failure and for the risk of re-intervention.
In this way, they can decide what is most important to them.
The models still need external validation.
Conclusion
Proper patient selection is the key for failure or
re-intervention of EA. Therefore, we propose two multi-
variate models to predict the chance of failure and surgi-
cal re-intervention within 2 years after EA. Due to the
permanent character of EA, the increasing number of
post-operative failure and re-interventions, these predic-
tion models could be useful for both the doctor and pa-
tient and may contribute to the shared decision-making.
Table 4 Clinical example
Variable Patient
1
Patient
2
Patient
3
Patient
4
Age (years) 38 42 45 48
Dysmenorrhea Yes No Yes No
Duration of menstruation > 7 days Yes No Yes No
Menorrhagia Yes Yes Yes Yes
Parity ≥ 5 Yes No No No
Previous caesarean section Yes No Yes No
Chance of failure of EA (%) 93% 84% 50% 28%
Chance of getting a surgical re-intervention
< 2 years after EA (%)
62% 26% 17% 4%
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Significant factors in these models are age, dysmenor-
rhea, duration of menstruation > 7 days, menorrhagia,
parity and previous caesarean section.
External validation of the models is being performed;
furthermore, we are performing a study to see the im-
pact of the models in the decision of both the patients
and the doctor.
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